Suppr超能文献

骨生成素作为小腿骨折辅助治疗的应用。

The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures.

作者信息

Morasiewicz Piotr, Zaborska Monika, Sobczak Michał, Tomczyk Łukasz, Leyko Paweł, Bobiński Andrzej, Kochańska-Bieri Joanna, Pili Daniele, Kazubski Krystian

机构信息

Department of Orthopaedic and Trauma Surgery, Institute of Medical Sciences, University of Opole, Witosa 26, 45-401 Opole, Poland.

Faculty of Medicine, Institute of Medical Sciences, University of Opole, Witosa 26, 45-401 Opole, Poland.

出版信息

Pharmaceuticals (Basel). 2024 Nov 14;17(11):1531. doi: 10.3390/ph17111531.

Abstract

The goal of the orthopedic treatment of fractures is to achieve bone union as rapidly as possible in the largest possible number of patients and to minimize the number of complications. The purpose of this study was to assess if the use of Osteogenon would have a positive effect on radiological and clinical parameters in patients with lower leg bone fractures treated with the Ilizarov method. We evaluated 26 patients who had their lower leg bone fractures treated with the Ilizarov method and received Osteogenon at our clinic in the years 2021-2023. The control group comprised 25 patients with lower leg bone fractures treated with the Ilizarov method who did not receive Osteogenon. We assessed the following parameters: time to achieving bone union, bone union rate, time to resuming normal physical activity, time to achieving pain relief, the number of patients reporting pain relief, and the rate of complications. The median time to achieve bone union after lower leg bone fracture treated with the Ilizarov method was shorter in the Osteogenon group (108.5 days) compared to the control group (134 days), < 0.001. Bone union was achieved in all the patients in the Osteogenon group and in 96% of the patients in the control group; the difference was not statistically significant. The median time to resuming normal physical activity was shorter in the Osteogenon group (22.5 weeks) compared to the control group (27 weeks), < 0.001. The median time to achieving pain relief was shorter in the Osteogenon group (21 weeks) compared to the control group (30 weeks), < 0.001. The proportion of patients who reported pain relief was 88.46% in the group receiving Osteogenon and 76% in the control group; this difference was not statistically significant. The number of complications was lower in the Osteogenon group (8 patients; 30.77%) compared to the control group (15 patients; 60%), = 0.035. The use of Osteogenon has a beneficial impact on the treatment of lower leg bone fractures with the Ilizarov method. Osteogenon shortens the time to achieve bone union. Moreover, the use of the ossein-hydroxyapatite complex helps reduce the number of complications and shortens the time to achieve pain relief and to resume normal activities.

摘要

骨科骨折治疗的目标是在尽可能多的患者中尽快实现骨愈合,并尽量减少并发症的数量。本研究的目的是评估使用骨生成素对采用伊里扎洛夫方法治疗的小腿骨折患者的影像学和临床参数是否有积极影响。我们评估了2021年至2023年期间在我们诊所采用伊里扎洛夫方法治疗小腿骨折并接受骨生成素治疗的26例患者。对照组包括25例采用伊里扎洛夫方法治疗小腿骨折但未接受骨生成素治疗的患者。我们评估了以下参数:实现骨愈合的时间、骨愈合率、恢复正常体力活动的时间、实现疼痛缓解的时间、报告疼痛缓解的患者数量以及并发症发生率。与对照组(134天)相比,骨生成素组采用伊里扎洛夫方法治疗小腿骨折后实现骨愈合的中位时间更短(108.5天),<0.001。骨生成素组的所有患者均实现了骨愈合,对照组为96%的患者;差异无统计学意义。与对照组(27周)相比,骨生成素组恢复正常体力活动的中位时间更短(22.5周),<0.001。与对照组(30周)相比,骨生成素组实现疼痛缓解的中位时间更短(21周),<0.001。接受骨生成素治疗组报告疼痛缓解的患者比例为88.46%,对照组为76%;该差异无统计学意义。与对照组(15例患者;60%)相比,骨生成素组的并发症数量更低(8例患者;30.77%),=0.035。使用骨生成素对采用伊里扎洛夫方法治疗小腿骨折有有益影响。骨生成素缩短了实现骨愈合的时间。此外,使用骨胶原-羟基磷灰石复合物有助于减少并发症数量,并缩短实现疼痛缓解和恢复正常活动的时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084f/11597424/24a23154008f/pharmaceuticals-17-01531-g001.jpg

相似文献

7
A new criterion for assessing Ilizarov treatment outcomes in nonunion of the tibia.评估胫骨骨不连Ilizarov治疗效果的新标准。
Arch Orthop Trauma Surg. 2021 May;141(5):879-889. doi: 10.1007/s00402-020-03571-8. Epub 2020 Aug 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验